Indefinite Delivery Contract SPE2DR25D3102

The federal contract IDV award SPE2DR25D3102 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. This IDC serves as a primary vehicle for providing these critical medical commodities to support military healthcare programs globally, encompassing the needs of the Department of Defense (DoD), United States Coast Guard, and other designated federal agencies and customers.

The original contract opportunity, a pre-solicitation for the DLA Troop Support Medical's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), aims to establish multiple Prime Vendor Contracts to provide worldwide pharmaceutical support. The procurement is an unrestricted, fully competitive acquisition expected to have an estimated total value of $30.3 billion, with awards made on a regional basis to at least three different contractors. The contract will have a 30-month base period and three 30-month option periods, utilizing a Lowest Price Technically Acceptable (LPTA) evaluation approach with the potential for a reverse auction to determine the final distribution fees.